Galen E.B. Wright

2.2k total citations
53 papers, 1.2k citations indexed

About

Galen E.B. Wright is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Galen E.B. Wright has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 17 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Galen E.B. Wright's work include Pharmacogenetics and Drug Metabolism (15 papers), Genetic Associations and Epidemiology (12 papers) and Genetic Neurodegenerative Diseases (9 papers). Galen E.B. Wright is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Genetic Associations and Epidemiology (12 papers) and Genetic Neurodegenerative Diseases (9 papers). Galen E.B. Wright collaborates with scholars based in Canada, South Africa and United States. Galen E.B. Wright's co-authors include Britt I. Drögemöller, Louise Warnich, Colin J.D. Ross, Michael R. Hayden, Bruce Carleton, Dana Niehaus, Jennifer A. Collins, Liezl Koen, Michael S. Pepper and Collet Dandara and has published in prestigious journals such as Neuron, The Lancet Neurology and Clinical Cancer Research.

In The Last Decade

Galen E.B. Wright

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galen E.B. Wright Canada 22 490 402 320 265 221 53 1.2k
Britt I. Drögemöller Canada 20 369 0.8× 366 0.9× 292 0.9× 146 0.6× 216 1.0× 54 1.0k
Yoram Cohen Israel 18 483 1.0× 123 0.3× 280 0.9× 83 0.3× 271 1.2× 47 1.3k
Rasmus Jansson‐Löfmark Sweden 26 466 1.0× 161 0.4× 176 0.6× 167 0.6× 187 0.8× 81 2.1k
Iris Grossman Israel 23 594 1.2× 147 0.4× 131 0.4× 251 0.9× 83 0.4× 43 1.4k
Vidar M. Steen Norway 14 354 0.7× 309 0.8× 190 0.6× 96 0.4× 130 0.6× 25 969
Joseph DeYoung United States 15 620 1.3× 178 0.4× 221 0.7× 84 0.3× 1.0k 4.6× 22 2.0k
Yuki Bradford United States 17 331 0.7× 269 0.7× 593 1.9× 47 0.2× 65 0.3× 38 1.4k
Rosario López‐Rodríguez Spain 17 481 1.0× 216 0.5× 77 0.2× 221 0.8× 108 0.5× 49 1.1k
Eileen P. Treacy Ireland 31 1.2k 2.5× 217 0.5× 400 1.3× 51 0.2× 100 0.5× 102 2.6k
Scott J. Hebbring United States 26 836 1.7× 162 0.4× 774 2.4× 75 0.3× 91 0.4× 67 2.0k

Countries citing papers authored by Galen E.B. Wright

Since Specialization
Citations

This map shows the geographic impact of Galen E.B. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen E.B. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen E.B. Wright more than expected).

Fields of papers citing papers by Galen E.B. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galen E.B. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen E.B. Wright. The network helps show where Galen E.B. Wright may publish in the future.

Co-authorship network of co-authors of Galen E.B. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Galen E.B. Wright. A scholar is included among the top collaborators of Galen E.B. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galen E.B. Wright. Galen E.B. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drögemöller, Britt I., Galen E.B. Wright, Clement Adebamowo, et al.. (2023). Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations. Clinical Pharmacology & Therapeutics. 115(3). 576–594. 2 indexed citations
2.
Drögemöller, Britt I., Galen E.B. Wright, Clement Adebamowo, et al.. (2022). Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations. Clinical Pharmacology & Therapeutics. 113(3). 643–659. 19 indexed citations
3.
Wright, Galen E.B., et al.. (2022). Common huntingtin-related genetic variation is associated with neurobiological and aging traits in humans. Cell Death Discovery. 8(1). 311–311. 1 indexed citations
4.
Wright, Galen E.B., Britt I. Drögemöller, Fudan Miao, et al.. (2021). Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity. npj Genomic Medicine. 6(1). 35–35. 7 indexed citations
5.
Hippman, Catriona, Emily Morris, Angela Inglis, et al.. (2021). A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancy. Archives of Women s Mental Health. 25(2). 355–365. 1 indexed citations
6.
Loucks, Catrina M., Britt I. Drögemöller, Galen E.B. Wright, et al.. (2021). Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment. Biomedicine & Pharmacotherapy. 143. 112195–112195. 2 indexed citations
7.
Wright, Galen E.B., Nicholas S. Caron, Bernard Ng, et al.. (2020). Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease. Human Molecular Genetics. 29(16). 2788–2802. 18 indexed citations
8.
Wright, Galen E.B., et al.. (2020). A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping. npj Genomic Medicine. 5(1). 30–30. 38 indexed citations
9.
Wright, Galen E.B., Jennifer A. Collins, Terence Gall-Duncan, et al.. (2020). Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies. The Lancet Neurology. 19(11). 930–939. 47 indexed citations
10.
Wright, Galen E.B., Jennifer A. Collins, Chris Kay, et al.. (2019). Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease. The American Journal of Human Genetics. 104(6). 1116–1126. 120 indexed citations
11.
Drögemöller, Britt I., Beth Brooks, Jose Gerard Monzon, et al.. (2018). Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients. Clinical Cancer Research. 24(8). 1866–1871. 28 indexed citations
12.
Kowalec, Kaarina, Galen E.B. Wright, Britt I. Drögemöller, et al.. (2016). Genome-wide scan identifies association between an interferon regulatory factor-related variant and interferon-beta induced liver injury in multiple sclerosis patients. Multiple Sclerosis Journal. 22(3). 834–836. 1 indexed citations
13.
Wright, Galen E.B., Bruce Carleton, Michael R. Hayden, & Colin J.D. Ross. (2016). The global spectrum of protein-coding pharmacogenomic diversity. The Pharmacogenomics Journal. 18(1). 187–195. 67 indexed citations
14.
Wang, Zhe, A. Dessa Sadovnick, Anthony Traboulsee, et al.. (2016). Case-Control Studies Are Not Familial Studies. Neuron. 92(2). 339–341. 6 indexed citations
15.
Wang, Zhe, A. Dessa Sadovnick, Anthony Traboulsee, et al.. (2016). Nuclear Receptor NR1H3 in Familial Multiple Sclerosis. Neuron. 90(5). 948–954. 65 indexed citations
16.
Drögemöller, Britt I., Ogechi Ikediobi, Lize van der Merwe, et al.. (2015). CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women. AIDS Research and Human Retroviruses. 32(6). 529–538. 16 indexed citations
17.
Drögemöller, Britt I., Galen E.B. Wright, & Louise Warnich. (2014). Considerations for rare variants in drug metabolism genes and the clinical implications. Expert Opinion on Drug Metabolism & Toxicology. 10(6). 873–884. 17 indexed citations
18.
Warnich, Louise, Britt I. Drögemöller, Michael S. Pepper, Collet Dandara, & Galen E.B. Wright. (2011). Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation. Current pharmacogenomics and personalized medicine (Online). 9(3). 191–207. 55 indexed citations
19.
Wright, Galen E.B. & Jeffrey A. Buck. (1991). Medicaid support of alcohol, drug abuse, and mental health services.. PubMed. 13(1). 117–28. 11 indexed citations
20.
Wright, Galen E.B.. (1990). Objective Assessment in Dementia: Automated Psychometric Tests and the P3. Neuroepidemiology. 9(4). 208–215. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026